Head to head for first-timers
CoreAge Rx vs No BS RX
CoreAge Rx and No BS RX both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
CoreAge Rx
Higher scoreRank #32 for first-timers · Grade C
Mama-Match
Best for: Someone comparing dose prices who can obtain the offer, state availability and order terms in writing.
Visit CoreAge RxNo BS RX
Rank #201 for first-timers · Grade C
Mama-Match
Best for: Someone who wants a cheap low-dose on-ramp and will ask, in writing, for the total including pharmacy charges before paying.
Visit No BS RXThe verdict for a first step
CoreAge Rx edges out No BS RX on the Mama-Match Score, 73 to 52 (C vs C). Someone comparing dose prices who can obtain the offer, state availability and order terms in writing.
No BS RX is still a genuine option — the whole table published and a low dose at $140 — but its “no platform fees” clashes with its own disclosures. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | CoreAge Rx | No BS RX |
|---|---|---|
| Mama-Match Score | 73/100 · C | 52/100 · C |
| Overall rank | #32 | #201 |
| Semaglutide | $99/mo | $179/mo |
| Tirzepatide | $149/mo | $249/mo |
| Coverage | Therapy-specific state restrictions; confirm eligibility | No list published; it says it is not in all of them |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Mama-Match
CoreAge Rx
Rank #32 · Grade C
What we like
- Published prices for both molecules, with the same advertised amount at each dose
- The offer includes medication, consultation and shipping, without an advertised membership fee
- The legal footer identifies the platform and the entities responsible for clinical care
The caveats
- The main site and a separate offer page show different prices
- The FAQ and policy differ on automatic rebilling and denial refunds
- State restrictions; orders become final when sent to pharmacy, with a 30-day refund cutoff
Mama-Match
No BS RX
Rank #201 · Grade C
What we like
- The full table is published before any intake
- A low-dose program at $140 a month: a gentle, cheap way in
- No price changes as the dose goes up, said outright
The caveats
- Its “no platform fees” clashes with its own disclosures
- Pharmacy, dispensing and shipping charges are paid separately, per its own fine print
- Platform fees are non-refundable once the clinical review has started
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and No BS RX with the other providers we review for women.
Or browse the full comparison hub.